Robert Kruse, MD, PhD
@RobertLKruse
Physician Scientist @UTMB, Biotech Entrepreneur, Clinical training at Harvard, Johns Hopkins; Yale alumnus, Opinions are my own, do not represent medical advise
982 Following 3.2K Followers
One of the biggest challenges I see for Claude and AI in biotech drug development is that LLMs are based on published data, patents, etc. But when industry (and my company) try to replicate published work, the failure rate is at least 50-65%. How does the AI know what to trust?
Show more
